医学
全直肠系膜切除术
结直肠癌
新辅助治疗
析因分析
封锁
外科
随机对照试验
放化疗
内科学
癌症
化疗
乳腺癌
受体
作者
Kai Pang,Xinzhi Liu,Hongwei Yao,Guole Lin,Yuanyuan Kong,Ang Li,Jiagang Han,Guoju Wu,Xin Wang,Yingjiang Ye,Jie Zhang,Guangyong Chen,Aiwen Wu,Yi Xiao,Yingchi Yang,Zhongtao Zhang
摘要
Neoadjuvant CRT plus PD1 blockade enhances pathological tumour regression and is beneficial to the successful implementation of TME in patients with LARC. Validations with larger sample sizes are warranted.
科研通智能强力驱动
Strongly Powered by AbleSci AI